Drugs / Angiostatin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00049790 | ? → Dec 2004 | non-small cell lung carcinoma | CASI pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Angiostatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00049790 ↗ |
| Modality | Protein / enzyme biologic | “rhAngiostatin protein administered in combination with paclitaxel and carboplatin” NCT00049790 ↗ |